Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...
Apollo Cradle and Children’s Hospital in partnership with MSD Pharmaceuticals launched ‘Together for Her Well-being,’ an initiative aimed at empowering women with knowledge about self-care ...
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") is pleased to announce the successful completion of its financial audits for the fiscal years 2022 and 2023 by ...
4d
ET Now on MSNAurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...
These young leaders are leveraging the insights and networks gained from the programme to create positive change in their communities and beyond.
Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...
MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.
The facility incorporates best practices and insights from across the company’s manufacturing division network.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results